You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Nexstim: Stimulating Earnings Turnaround
Nexstim is a medical technology company, whose transcranial magnetic stimulation technology is used in pre-operative brain mapping and to treat neurological diseases and disorders. This technologically advanced niche player has a commercialization in relatively early stages and has been loss-making throughout its history. This year we expect a profitable result, supported by a non-recurring license fee. Analyst Antti Siltanen guides through technology, income streams, business model, future outlook and valuation.
Content:
00:00 Introduction
00:12 Technology and innovation
03:06 How does the technology work?
04:31 Customers, business idea and income streams
05:50 Regulation, R&D, and approval of the technology
07:48 Company history
10:00 Business segments + new openings with technology licensing
13:45 Pros, cons and restrictions regarding the licensing deal with Magnus medical
17:31 Joint ventures with TMS clinics in the US
19:10 The nature of the investment in the clinic
20:07 Sales in detail
21:22 Sales organization
22:08 Potential and cost structure
23:27 Valuation
27:15 H1’22 comments
Graphics: Inderes and Nexstim
Read the latest research, published 2022-08-16:
https://www.inderes.se/research/stimulating-earnings-turnaround
Read more about Nexstim: https://www.inderes.se/companies/Nexstim